A detailed history of Baker Bros. Advisors LP transactions in Celcuity Inc. stock. As of the latest transaction made, Baker Bros. Advisors LP holds 1,874,978 shares of CELC stock, worth $24 Million. This represents 0.3% of its overall portfolio holdings.

Number of Shares
1,874,978
Previous 1,874,978 -0.0%
Holding current value
$24 Million
Previous $30.7 Million 8.98%
% of portfolio
0.3%
Previous 0.41%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$14.1 - $20.78 $4.55 Million - $6.7 Million
322,500 Added 20.77%
1,874,978 $30.7 Million
Q1 2024

May 15, 2024

BUY
$13.74 - $21.6 $14 Million - $22 Million
1,017,000 Added 189.92%
1,552,478 $33.5 Million
Q3 2023

Nov 14, 2023

BUY
$8.96 - $10.75 $4.8 Million - $5.76 Million
535,478 New
535,478 $4.89 Million

Others Institutions Holding CELC

About Celcuity Inc.


  • Ticker CELC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 14,941,300
  • Market Cap $191M
  • Description
  • Celcuity Inc., a clinical stage biotechnology company, focuses on the development of molecularly targeted therapies for cancer patients in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therap...
More about CELC
Track This Portfolio

Track Baker Bros. Advisors LP Portfolio

Follow Baker Bros. Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Baker Bros. Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Baker Bros. Advisors LP with notifications on news.